about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
0.82
-0.05
(-5.75%)
1.4M
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..